Maternal serum placental growth factor and α‐fetoprotein testing in first trimester screening for Down syndrome
Authors:
- 26 March 2013
- journal article
- research article
- Published by Wiley in Prenatal Diagnosis
- Vol. 33 (5) , 457-461
Abstract
Objective: The aim of this research was to evaluate the addition of first trimester maternal serum placental growth factor (PlGF) and α‐fetoprotein (AFP) to the combined test for Down syndrome and a serum only protocol of PlGF, AFP, free β‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐A.Methods: Samples were from 92 Down syndrome cases with 552 matched controls. All women had a combined test at 11–14 weeks gestation. PlGF and AFP were measured and expressed in multiples of the gestation‐specific median (MoM), adjusting for maternal weight and smoking status. Multivariate Gaussian modeling was used to predict detection and false‐positive rates.Results: The median PlGF level in the cases was 0.694 MoM and controls 1.000 MoM (p = p < 0.0001). Statistical modeling predicted that for a given false‐positive rate, the addition of PlGF to the combined test increases the detection rate by 4–7%. For a given detection rate, the false‐positive rate could be almost halved. When both PlGF and AFP are used, the detection rate increase is 5–8%. A serum only protocol had a predicted a detection rate of 71% for a false‐positive rate of 5%.Conclusions: Results suggest a substantial benefit of adding PlGF to the combined test. © 2013 John Wiley & Sons, Ltd.Keywords
This publication has 16 references indexed in Scilit:
- First‐trimester combined screening for trisomy 21 with different combinations of placental growth factor, free β‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐AUltrasound in Obstetrics & Gynecology, 2012
- Maternal Serum Placental Growth Factor in Prospective Screening for Aneuploidies at 8–13 Weeks’ GestationFetal Diagnosis and Therapy, 2012
- Maternal Serum α-Fetoprotein at 11–13 Weeks’ Gestation in Spontaneous Early Preterm DeliveryFetal Diagnosis and Therapy, 2011
- Prediction of early, intermediate and late pre‐eclampsia from maternal factors, biophysical and biochemical markers at 11–13 weeksPrenatal Diagnosis, 2011
- Modeling Down syndrome screening performance using first‐trimester serum markersUltrasound in Obstetrics & Gynecology, 2010
- First trimester maternal serum placental growth factor in trisomy 21 pregnanciesPrenatal Diagnosis, 2010
- Multi‐Marker Maternal Serum Screening for Chromosomal Abnormalities2009
- Maternal serum placental growth factor at 11–13 weeks in chromosomally abnormal pregnanciesUltrasound in Obstetrics & Gynecology, 2009
- Age‐standardisation when target setting and auditing performance of Down syndrome screening programmesPrenatal Diagnosis, 2004
- Model‐based screening by risk with application to down's syndromeStatistics in Medicine, 1992